Michael P Dube

VP, Chief Accounting Officer, Intellia Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.1M

Companies

Latest trade

Oct 2, 2026

Companies

Intellia Therapeutics, Inc.VP, Chief Accounting Officer −$0.1M

Trades

NTLA Sold 1,864 shares at $12.43 $0.0M Oct 2

NTLA Sold 2,641 shares at $16.78 $0.0M Jul 1

NTLA Sold 2,989 shares at $9.21 $0.0M Jan 5

NTLA Sold 1,871 shares at $17.38 $0.0M Oct 1

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.